Alliance Pharma (APH)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

64.60p
   
  • Change Today:
      0.20p
  • 52 Week High: 65.00
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 540.57m
  • Volume: 68,119
  • Market Cap: £349.21m
  • RiskGrade: 119
  • Beta: 0.01

Alliance Pharma Overview

Our Vision is to be a leading international healthcare business, built around products that are clinically valuable to patients.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -4.5% 20.5%
ROCE n/a  
Latest F'cast
P/E 14.9 12.9
PEG n/a 0.8
Pr/Revenue 1.9 1.7
Pr/Book 1.7  
Latest F'cast
Revenue -1.0% 12.3%
PBT n/a n/a
EPS -4.8% 15.4%
DPS n/a n/a

Alliance Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 129.80 13.02 5.11p 17.1 n/a 0% 1.61p 1.8%
31-Dec-21 163.21 18.16 6.39p 17.0 0.7 +25% 1.69p 1.6%
31-Dec-22 167.42 (23.05) 4.28p 12.4 n/a -33% 1.78p 3.4%
31-Dec-23 180.68 (48.80) 4.54p 8.9 1.5 +6% n/a 0.0%
31-Dec-24 178.84 (14.46) 4.32p 10.6 n/a -5% n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Alliance Pharma Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 200.75 41.16 4.99p 12.9 0.8 +15% n/a 0.0%
31-Dec-26 210.82 44.50 5.59p 11.5 1.0 +12% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Alliance Pharma Company Announcements

Form 8.3 ALLIANCE PHARMA PLC 25-Apr-2025 15:06 RNS
Form 8.5 (EPT/RI) - Alliance Pharma plc 25-Apr-2025 10:36 RNS
Form 8.5 (EPT/RI) - Alliance Pharma plc 25-Apr-2025 09:22 GlobeNewswire NA

Alliance Pharma ShareCast News

Alliance Pharma confident despite softer sales 08-Apr-2025 ShareCast
Alliance Pharma agrees to take-private deal 10-Mar-2025 ShareCast
Alliance Pharma FY profits seen in line with exp... 31-Jan-2025 ShareCast

Alliance Pharma Top Newspaper Links

Drug sales lead the way for Boots as revenues ri... 31-Oct-2008 The Scotsman
Look ahead 13-Sep-2006 Times
Look ahead 12-May-2006 Times

Latest Alliance Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Alliance Pharma Market Data

Currency UK Pounds
Share Price 64.60p
Change Today 0.20p
% Change 0.31 %
52 Week High 65.00
52 Week Low 29.35
Volume 68,119
Shares Issued 540.57m
Market Cap £349.21m
Beta 0.01
RiskGrade 119

Alliance Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
21.93% above the market average21.93% above the market average21.93% above the market average21.93% above the market average21.93% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
85.31% above the market average85.31% above the market average85.31% above the market average85.31% above the market average85.31% above the market average
95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average95.83% above the sector average
Income Not Available
Growth
51.25% below the market average51.25% below the market average51.25% below the market average51.25% below the market average51.25% below the market average
56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average56.25% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 5
Sell 1
Strong Sell 0
Total 8
neutral
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Alliance Pharma Dividends

  Latest Previous
  Final Interim
Ex-Div 22-Jun-23 22-Dec-22
Paid 18-Jul-23 19-Jan-23
Amount 1.18p 0.59p

Trades for 25-Apr-2025

Time Volume / Share Price
13:53 400 @ 64.43p
13:50 4,278 @ 64.43p
12:31 10,000 @ 64.40p
12:31 10,000 @ 64.40p
12:23 1,542 @ 64.49p

Alliance Pharma Key Personnel

CFO Andrew Franklin
Chair Camillo Pane
CEO Nick Sedgwick

Top of Page